Rank #1687UTHR

United Therapeutics Corporation

$480.52

0.94% (Daily)

Market Cap

$21.73B

Revenue

$3.13B

Rank by MCap

#1687

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Dr. Martine A. Rothblatt J.D., M.B.A., Ph.D.

Headquarters

Silver Spring, MD

Employees

1,305

About United Therapeutics Corporation

United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. The company offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension (PAH) t...